Abstract: Provide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Provided is a novel prophylactic and/or therapeutic agent for Clostridium difficile infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Clostridium difficile infection. The prophylactic and/or therapeutic agent for Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Provided is a growth inhibitor for Clostridioides difficile. A growth inhibitor for Clostridioides difficile, comprising killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer or a detergent for inhibiting the growth of Clostridioides difficile.

Abstract: A radio frequency amplifying device according to an embodiment includes load impedance calculating circuitry and controlling circuitry. The load impedance calculating circuitry is configured to calculate a load impedance on the basis of information about a voltage standing wave rate and a phase on an output side of radio frequency amplifying circuitry. The controlling circuitry is configured to adjust a gain and a phase of a signal to be input to the radio frequency amplifying circuitry, in accordance with the load impedance calculated by the load impedance calculating circuitry.

Abstract: A radio frequency amplifying device according to an embodiment includes amplifying circuitry, obtaining circuitry, and correcting circuitry. The amplifying circuitry is configured to output an amplified signal obtained by amplifying a signal input thereto. The obtaining circuitry is configured to obtain an envelope indicating a waveform of a radio frequency signal as digital data. The correcting circuitry is configured to correct the obtained envelope on the basis of a rising characteristic of the amplifying circuitry and to input the signal generated on the basis of the envelope resulting from the correction to the amplifying circuitry.

Abstract: Provided is a novel prophylactic and/or therapeutic agent for Clostridium difficile infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Clostridium difficile infection. The prophylactic and/or therapeutic agent for Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Provide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: A radio frequency power supply according to an embodiment is a radio frequency power supply that amplifies an input signal including application timing of a radio frequency magnetic field and waveform information and that supplies the amplified input signal to a radio frequency coil. The radio frequency power supply includes an amplifier and a controlling unit. The amplifier amplifies the input signal and to output an amplified signal. The controlling circuity varies power supply voltage used by the amplifier for the amplification of the input signal, in accordance with the input signal.

Abstract: Provided is a reinforcing material having high interfacial adhesion with a matrix resin. The reinforcing material containing a covering layer according to an embodiment of the present invention includes a reinforcing material that imparts strength to a matrix resin by being combined with the matrix resin, and a covering layer formed on a surface of the reinforcing material, in which the covering layer is formed of a vaporized material generated by heating the resin.

Abstract: Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus have been found to be capable of protecting against MRSA infection. The MRSA infection protective agent comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus; and a food for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: A radio frequency amplifying device according to an embodiment includes load impedance calculating circuitry and controlling circuitry. The load impedance calculating circuitry is configured to calculate a load impedance on the basis of information about a voltage standing wave rate and a phase on an output side of radio frequency amplifying circuitry. The controlling circuitry is configured to adjust a gain and a phase of a signal to be input to the radio frequency amplifying circuitry, in accordance with the load impedance calculated by the load impedance calculating circuitry.

Abstract: Provided is a novel prophylactic and/or therapeutic agent for Pseudomonas aeruginosa infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. The prophylactic and/or therapeutic agent for Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: The present invention provides a gelling composition for preparing a gelatinous food which do not dissolve even when reheated (e.g., dysphagia diet). The present invention provides a gelling composition for preparing a gelatinous food which retains its original shape even when reheated, wherein the gelling composition comprises a water-soluble polymer capable of forming a thermo-irreversible gel. Also provided is a method of gelling a food and enhancing the shape-retaining property of the food against reheating by using the above-described gelling composition, as well as a method of preparing a gelatinous food which retains its original shape even when reheated by using the above-described gelling composition.

Abstract: A radio frequency amplifying device according to an embodiment includes amplifying circuitry, obtaining circuitry, and correcting circuitry. The amplifying circuitry is configured to output an amplified signal obtained by amplifying a signal input thereto. The obtaining circuitry is configured to obtain an envelope indicating a waveform of a radio frequency signal as digital data. The correcting circuitry is configured to correct the obtained envelope on the basis of a rising characteristic of the amplifying circuitry and to input the signal generated on the basis of the envelope resulting from the correction to the amplifying circuitry.

Abstract: Provided is a composition for improving the nutritional status, reducing the frequency of fever, and/or increasing the immunocompetence of the elderly. The composition is one for improving the nutritional status, reducing the frequency of fever, and/or increasing the immunocompetence of the elderly and comprises the following components (a) to (e): (a) an antioxidant agent; (b) at least one component selected from the group consisting of vitamin B1, vitamin B2, vitamin B6, niacin, and pantothenic acid; (c) at least one component selected from the group consisting of folic acid and vitamin B12; (d) zinc; and (e) selenium.

Abstract: A radio frequency power supply according to an embodiment is a radio frequency power supply that amplifies an input signal including application timing of a radio frequency magnetic field and waveform information and that supplies the amplified input signal to a radio frequency coil. The radio frequency power supply includes an amplifier and a controlling unit. The amplifier amplifies the input signal and to output an amplified signal. The controlling circuity varies power supply voltage used by the amplifier for the amplification of the input signal, in accordance with the input signal.

Abstract: Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus have been found to be capable of protecting against MRSA infection, The MRSA infection protective agent comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus; and a food for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus.

Abstract: Disclosed is a composition for reducing the levels or level of glucose, malondialdehyde-modified LDL, homocysteine, and/or C-reactive protein in the blood. Specifically disclosed is a composition for reducing the level of at least one substance selected from the group consisting of glucose, malondialdehyde-modified LDL, homocysteine, and C-reactive protein in the blood, which comprises the following components (a) and (b): (a) at least one component selected from the group consisting of vitamin B12, vitamin B6, and folic acid; and (b) at least one component selected from the group consisting of zinc, selenium, and an antioxidant vitamin.

Abstract: The present invention provides a gelling composition for preparing a gelatinous food which do not dissolve even when reheated (e.g., dysphagia diet). The present invention provides a gelling composition for preparing a gelatinous food which retains its original shape even when reheated, wherein the gelling composition comprises a water-soluble polymer capable of forming a thermo-irreversible gel. Also provided is a method of gelling a food and enhancing the shape-retaining property of the food against reheating by using the above-described gelling composition, as well as a method of preparing a gelatinous food which retains its original shape even when reheated by using the above-described gelling composition.

Abstract: The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.